The p53 family in differentiation and tumorigenesis

Cited by (310)

Items 101–200 of 310

1. Identification of essential transcription factors for adequate DNA damage response after benzo(a)pyrene and aflatoxin B1 exposure by combining transcriptomics with functional genomics
   Evelyn Smit, Terezinha Maria de Souza, Danyel G. J. Jennen, Jos C. S. Kleinjans, Twan van den Beucken · 2017 · Toxicology
2. p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress
   Zhenlin Yang, Daniela Kenzelmann Brož, William L Noderer, Joshua P. Ferreira, K. Wesley Overton, Sabrina L. Spencer, Tobias Meyer, Stephen J. Tapscott, Laura Donatella Attardi, Clifford L. Wang · 2014 · Cell Death and Differentiation
3. Tumor Suppressor Protein p53 Regulates Megakaryocytic Polyploidization and Apoptosis
   Peter G. Fuhrken, Pani A. Apostolidis, Stephan C. Lindsey, William M. Miller, Eleftherios Terry Papoutsakis · 2008 · Journal of Biological Chemistry
4. The regulation of radiosensitivity by p53 and its acetylation
   Jing Zhang, Liangfang Shen, Lun‐Quan Sun · 2015 · Cancer Letters
5. Regulation of p53 in embryonic stem cells
   Valeria Solozobova, Christine Blattner · 2010 · Experimental Cell Research
6. TP63 and TP73 in cancer, an unresolved “family” puzzle of complexity, redundancy and hierarchy
   Antonio Costanzo, Natalia Pediconi, Alessandra Narcisi, Francesca Guerrieri, Laura Belloni, Francesca Fausti, Elisabetta Botti, Massimo Levrero · 2014 · FEBS Letters
7. Expression and prognostic relevance of centromere protein A in primary osteosarcoma
   GU Xiao-min, Jie Fu, Xiaojun Feng, Xue Song Huang, Shou‐Mei Wang, Xinfeng Chen, Ming-hua Zhu, Shuhui Zhang · 2014 · Pathology - Research and Practice
8. A p53-Pax2 Pathway in Kidney Development: Implications for Nephrogenesis
   Zubaida R. Saifudeen, Jiao Liu, Susana Dipp, Xiao Yao, Yuwen Li, Nathaniel McLaughlin, Karam Aboudehen, Samir Sayem El-Dahr · 2012 · PLoS ONE
9. Therapeutic targeting of the p53 pathway in cancer stem cells
   Varun V. Prabhu, Joshua E. Allen, Bo Hong, Shengliang Zhang, Hairong Cheng, Wafik S. El‐Deiry · 2012 · Expert Opinion on Therapeutic Targets
10. Pharmacological Modulators of the Circadian Clock as Potential Therapeutic Drugs: Focus on Genotoxic/Anticancer Therapy
    Marina P. Antoch, Roman V. Kondratov · 2013 · Handbook of experimental pharmacology
11. Targeting p73 in cancer
    Anna-Maria Maas, Anne Catherine Bretz, Elisabeth Mack, Thorsten Stiewe · 2011 · Cancer Letters
12. p53 control of bone remodeling
    Huijuan Liu, Baojie Li · 2010 · Journal of Cellular Biochemistry
13. microRNA Expression and Biogenesis in Cellular Response to Ionizing Radiation
    Aihong Mao, Yang Liu, Hong Zhang, Cuixia Di, Chao Sun · 2014 · DNA and Cell Biology
14. Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy
    Tingting Liu, Zhongyu Wu, Yujing He, Yuliang Xiao, Chengcai Xia · 2020 · European Journal of Medicinal Chemistry
15. p73 as a Pharmaceutical Target for Cancer Therapy
    Andrea Bisso, Licio Collavin, Giannino Del Sal · 2011 · Current Pharmaceutical Design
16. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites
    Masashi Idogawa, Tomoko Ohashi, Yasushi Sasaki, Reo Maruyama, Lisa Kashima, Hiromu Suzuki, Takashi Tokino · 2014 · Human Molecular Genetics
17. Periosteal osteosarcoma: a review of clinical evidence.
    Xinwei Liu, Ying Zi, Liangbi Xiang, Tianyu Han · 2015 · Europe PMC (PubMed Central)
18. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation
    Ximena Montano · 2009 · Oncogene
19. Molecular control of brain size: Regulators of neural stem cell life, death and beyond
    Bertrand Joseph, Ola Hermanson · 2010 · Experimental Cell Research
20. Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro
    Kathleen Boehme, Yasmin Dietz, Philip G. Hewitt, Stefan O. Mueller · 2010 · Toxicology Letters
21. USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53
    Feroz Sarkari, Yi Sheng, Lori Frappier · 2010 · PLoS ONE
22. An insight into the anticancer mechanism of Tribulus terrestris extracts on human breast cancer cells
    Apurva Patel, Anjali Soni, Nikhat Jamal Siddiqi, Preeti Sharma · 2019 · 3 Biotech
23. Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures
    Sven de Mey, Inès Dufait, Mark De Ridder · 2021 · Frontiers in Oncology
24. Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
    Elizabeth M Freeburg, Alicia Alejandra Goyeneche, Erin E. Seidel, Carlos Marcelo Telleria · 2009 · Cancer Cell International
25. TP53 promotes lineage commitment of human embryonic stem cells through ciliogenesis and sonic hedgehog signaling
    Sushama Sivakumar, Shutao Qi, Ningyan Cheng, Adwait Amod Sathe, Mohammed Kanchwala, Ashwani Kumar, Bret M. Evers, Chao Xing, Hongtao Yu · 2022 · Cell Reports
26. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor
    Barbara Testoni, Valeria Schinzari, Francesca Guerrieri, Sabine Gerbal‐Chaloin, Giovanni Blandino, Massimo Levrero · 2011 · Oncogene
27. RETRA exerts anticancer activity in Ewing’s sarcoma cells independent of their TP53 status
    Jürgen Sonnemann, Désirée Grauel, Lisa Blümel, Julia Hentschel, Christian Marx, Annelie Blumrich, Katharina Focke, Sabine Becker, Susan Wittig, Sandra Schinkel et al. · 2015 · European Journal of Cancer
28. Inhibition of Apoptosis Reduces Diploidization of Haploid Mouse Embryonic Stem Cells during Differentiation
    Wenhao Zhang, Yaru Tian, Qian Gao, Xu Li, Yanni Li, Jinxin Zhang, Chunmeng Yao, Yuna Wang, Haoyu Wang, Yiding Zhao et al. · 2020 · Stem Cell Reports
29. The Intricate Role of p53 in Adipocyte Differentiation and Function
    Yun Kyung Lee, Yu Seong Chung, Ji Hye Lee, Jin Mi Chun, Jun Hong Park · 2020 · Cells
30. Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics
    Shiv K. Singh, Volker Ellenrieder · 2013 · Gut
31. CRKL oncogene is downregulated by p53 through miR‐200s
    Miyuki Tamura, Yasushi Sasaki, Kenta Kobashi, Kousuke Takeda, Takafumi Nakagaki, Masashi Idogawa, Takashi Tokino · 2015 · Cancer Science
32. KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
    Yogesh K. Chutake, Michele Mayo, Nancy Dumont, Jessica Filiatrault, Susanne B. Breitkopf, Patricia Cho, Dapeng Chen, Vaishali S. Dixit, William R. Proctor, Eric W. Kuhn et al. · 2024 · Molecular Cancer Therapeutics
33. A New Coactivator Function for Zac1's C2H2 Zinc Finger DNA-Binding Domain in Selectively Controlling PCAF Activity
    Anke Hoffmann, Dietmar Spengler · 2008 · Molecular and Cellular Biology
34. Driving Apoptosis-relevant Proteins Toward Neural Differentiation
    Susana Solá, Márcia M. Aranha, Cecília M. P. Rodrigues · 2012 · Molecular Neurobiology
35. Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma
    Tomohiro Yamaki, Yusuke Suenaga, Toshihiko Iuchi, Jennifer Alagu, Atsushi Takatori, Makiko Itami, Akinobu Araki, Miki Ohira, Masahiro Inoue, Hajime Kageyama et al. · 2013 · Scientific Reports
36. Cross‐talk between Myc and p53 in B‐cell lymphomas
    Yu Li, Tiantian Yu, Ken H. Young · 2019 · Chronic Diseases and Translational Medicine
37. Alternative Splicing Targeting the hTAF4-TAFH Domain of TAF4 Represses Proliferation and Accelerates Chondrogenic Differentiation of Human Mesenchymal Stem Cells
    Jekaterina Kazantseva, Anri Kivil, Kairit Tints, Anna Kazantseva, Toomas Neuman, Kaia Palm · 2013 · PLoS ONE
38. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer
    Xiaoqun Dong, Yanan Li, Ping Chang, Kenneth R. Hess, James L. Abbruzzese, Donghui Li · 2011 · Molecular Carcinogenesis
39. Functional Diversification after Gene Duplication: Paralog Specific Regions of Structural Disorder and Phosphorylation in p53, p63, and p73
    Helena Gomes Dos Santos, Janelle Nunez-Castilla, Jessica Siltberg-Liberles · 2016 · PLoS ONE
40. TATA-binding Protein (TBP)-like Protein Is Required for p53-dependent Transcriptional Activation of Upstream Promoter of p21 Gene
    Hidefumi Suzuki, Ryo Ito, Kaori Ikeda, Tomohiro Tamura · 2012 · Journal of Biological Chemistry
41. Epidermal overexpression of transgenic ΔNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF‐κB activation
    Jihui Du, Rose‐Anne Romano, Han Si, Austin K. Mattox, Yansong Bian, Xinping Yang, Satrajit Sinha, Carter Van Waes, Zhong Chen · 2013 · The Journal of Pathology
42. Bcl-2/MDM2 Dual Inhibitors Based on Universal Pyramid-Like α-Helical Mimetics
    Ziqian Wang, Ting Song, Yingang Feng, Zongwei Guo, Yudan Fan, Wenjie Xu, Lu Liu, Anhui Wang, Zhichao Zhang · 2016 · Journal of Medicinal Chemistry
43. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation
    Jian Huang, Keqiang Chen, Jiaqiang Huang, Wanghua Gong, Nancy M. Dunlop, O. M. Zack Howard, Xiuwu Bian, Yuqi Gao, Ji Ming Wang · 2008 · Carcinogenesis
44. BTK blocks the inhibitory effects of MDM2 on p53 activity
    Miran Rada, Mohammad Althubiti, Akang E. Ekpenyong‐Akiba, Koon-Guan Lee, Kong‐Peng Lam, Olga Fedorova, Nickolai A. Barlev, Salvador Macip · 2017 · Oncotarget
45. BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity
    Wenjing Yang, Yun‐Fan Sun, Anli Jin, Li-Hua Lv, Jie Zhu, Beili Wang, Yan Zhou, Chunyan Zhang, Hao Wang, Bo Hu et al. · 2020 · Cell Death and Disease
46. Efficacy of cetuximab and panitumumab in oral squamous cell carcinoma cell lines: Prognostic value of MAGE-A subgroups for treatment success
    Stefan Hartmann, Ulrike Kriegebaum, Nora Küchler, Grit Lessner, Roman Camillus Brands, Christian Linz, Tim Schneider, Alexander Christian Kübler, Urs D. A. Müller-Richter · 2013 · Journal of Cranio-Maxillofacial Surgery
47. Viral Carcinogenesis
    Alyson J Smith, L.A. Smith · 2016 · Progress in molecular biology and translational science
48. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme
    Marek Mazurek, Cezary Grochowski, Jakub Litak, Ida Osuchowska, Ryszard Maciejewski, Piotr Kamieniak · 2020 · International Journal of Molecular Sciences
49. Structural Basis for ASPP2 Recognition by the Tumor Suppressor p73
    Peter Canning, F. von Delft, Alex N. Bullock · 2012 · Journal of Molecular Biology
50. Synthetic Condensed 1,4-naphthoquinone Derivative Shifts Neural Stem Cell Differentiation by Regulating Redox State
    Daniela Maria dos Santos, Maria M. M. Santos, Rui Moreira, Susana Solá, Cecília M. P. Rodrigues · 2012 · Molecular Neurobiology
51. p73 Plays a Role in Erythroid Differentiation through GATA1 Induction
    Fernándo Marqués-García, Nuria Ferrándiz, Rosalía Fernández-Alonso, Laura González-Cano, Marta Herreros‐Villanueva, Manuel Rosa‐Garrido, Belén Fernández‐García, Jose Pedro Vaque, Margarita M. Marqués, María Eugenia Alonso-Ferrero et al. · 2009 · Journal of Biological Chemistry
52. Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells
    Stefan Hartmann, Ulrike Kriegebaum, Nora Küchler, Roman Camillus Brands, Christian Linz, Alexander Christian Kübler, Urs D. A. Müller-Richter · 2013 · Clinical Oral Investigations
53. Partial p53 reactivation is sufficient to induce cancer regression
    Boris Klimovich, Laura Meyer, Nastasja Merle, Michelle M. Neumann, Alexander Marc König, Nikolaos Ananikidis, Corinna Ulrike Keber, Sabrina Elmshäuser, Oleg N. Timofeev, Thorsten Stiewe · 2022 · Journal of Experimental & Clinical Cancer Research
54. Apoptotic Cell Death in Neuroblastoma
    Yuanyuan Li, Akira Nakagawara · 2013 · Cells
55. Identification and characterization of a metastatic suppressor BRMS 1L as a target gene of p53
    Ryota Koyama, Miyuki Tamura, Takafumi Nakagaki, Tomoko Ohashi, Masashi Idogawa, Hiromu Suzuki, Takashi Tokino, Yasushi Sasaki · 2017 · Cancer Science
56. Synthesis and Biological Evaluation of Novel Dispiro-Indolinones with Anticancer Activity
    Yan A. Ivanenkov, Maxim E. Kukushkin, Anastasia A. Beloglazkina, Radik R. Shafikov, Alexander A. Barashkin, Andrey A. Ayginin, Marina S. Serebryakova, Alexander G. Majouga, Dmitry Aleksandrovich Skvortsov, В. А. Тафеенко et al. · 2023 · Molecules
57. Small-Molecule Inhibitors of Protein–Protein Interactions
    Zhihong Liu, H. Chen, Eric A. Wold, Jia Zhou · 2016 · Elsevier eBooks
58. Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine via the ROS/HIF-1A Signaling Pathway in an in Vitro Cerebral Ischemia/Reperfusion Injury Model
    Chunbing Zhang, Meihong Shen, Fengmeng Teng, Pengfei Li, Feng Gao, Juan Tu, Linjiao Luo, Chih‐Kuang Yeh, Dong Zhang · 2018 · Ultrasound in Medicine & Biology
59. TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene
    Yusuke Suenaga, Toshinori Ozaki, Yuji Tanaka, Youquan Bu, Takehiko Kamijo, Takeshi Tokuhisa, Akira Nakagawara, Tomohiro Tamura · 2009 · Journal of Biological Chemistry
60. Sprouty 2 Regulates DNA Damage-induced Apoptosis in Ras-transformed Human Fibroblasts
    Piro Lito, Bryan D. Mets, Daniel M. Appledorn, Veronica M. Maher, J. Justin McCormick · 2008 · Journal of Biological Chemistry
61. p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies
    Juan Wang, Xuefeng Wang, Shuyang Xie, Zhonghai Yan, Zunling Li, Youjie Li, Lei Wang, Fei Jiao · 2010 · Digestive Diseases and Sciences
62. Targeted Deletion of p73 in Mice Reveals Its Role in T Cell Development and Lymphomagenesis
    Alice Nemajerová, Gustavo F. Palacios, Norma J. Nowak, Seiichi Matsui, Oleksi Petrenko · 2009 · PLoS ONE
63. p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy
    Christie Rodriguez-Ramirez, Jacques Eduardo Nor · 2018 · Critical Reviews™ in Oncogenesis
64. Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability
    Maddalen Jiménez, María Arechederra, Matias Antonio Avila, Carmen Berasain · 2018 · Translational Gastroenterology and Hepatology
65. Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis
    Liangdong Jiang, Tao Cheng, HE Ai-yong · 2013 · Tumor Biology
66. Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney
    Yuwen Li, Jiao Liu, Nathan McLaughlin, Dimcho R Bachvarov, Zubaida R. Saifudeen, Samir Sayem El-Dahr · 2013 · Physiological Genomics
67. p53 Mutant p53N236S Induces Neural Tube Defects in Female Embryos
    Jinzhi Zhao, Yingbing Tian, Huihui Zhang, Lianhua Qu, Yu Chen, Qing Liu, Ying Luo, Xiaoming Wu · 2019 · International Journal of Biological Sciences
68. p53 functional loss, stemness and hepatocellular carcinoma
    Claude Caron de Fromentel, Massimo Levrero · 2020 · Hepatoma Research
69. Apoptosis Induction in MV4-11 and K562 Human Leukemic Cells by Pereskia sacharosa (Cactaceae) Leaf Crude Extract
    Siti Asmaa Mat Jusoh, Hamid Ali Nagi Al‐Jamal, Cheng Yong Ang, Jamaruddin Mat Asan, Azman Seeni, Muhammad Farid Johan · 2014 · Asian Pacific Journal of Cancer Prevention
70. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review
    Chowdhury Lutfun Nahar Metu, Sunita Kumari Sutihar, Md Sohel, Fatematuz Zohora, Akayed Hasan, Md. Thandu Miah, Tanu Rani Kar, Md. Arju Hossain, Md Habibur Rahman · 2023 · Cancer Reports
71. CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma
    Jie Min, Wei Zhang, Yu Gu, Liu Hong, Yao Li, Fanfan Li, Daqing Zhao, Yingming Feng, Helong Zhang, Qing Li · 2010 · Medical Oncology
72. Regulation of p53 under hypoxic and inflammatory conditions in periodontium
    Svenja Beisel-Memmert, Lina Gölz, Peter Pütz, Andreas Jäger, James Deschner, T. Appel, Georg Baumgarten, Birgit Rath-Deschner, Stilla Frede, Werner Götz · 2015 · Clinical Oral Investigations
73. Low-level overexpression of p53 promotes warfarin-induced calcification of porcine aortic valve interstitial cells by activating Slug gene transcription
    Li Ping Gao, Yue Ru Ji, Yan Lu, Ming Qiu, Yejiao Shen, Yaqing Wang, Xiangqing Kong, Yongfeng Shao, Yanhui Sheng, Wei Yue Sun · 2018 · Journal of Biological Chemistry
74. p73 isoforms meet evolution of metastasis
    Stella Logotheti, Athanasia Pavlopoulou, Stephan Marquardt, Işıl Takan, Alexandros G. Georgakilas, Thorsten Stiewe · 2022 · Cancer and Metastasis Reviews
75. Increased expression of p73Δex2 transcript in uveal melanoma with loss of chromosome 1p
    Emine Kılıç, Hennie T. Brüggenwirth, Marit Meier, Nicole C. Naus, H. Berna Beverloo, Jules P.P. Meijerink, Gré P.M. Luyten, Annelies de Klein · 2008 · Melanoma Research
76. Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction
    Mariell Pettersson, Maria Quant, Jaeki Min, Luigi I. Iconaru, Richard W. Kriwacki, Michael Brett Waddell, Rodney Kiplin Guy, Kristina Luthman, Morten Grøtli · 2015 · PLoS ONE
77. P53 Promotes Retinoid Acid-induced Smooth Muscle Cell Differentiation by Targeting Myocardin
    Zhou Tan, Jingya Li, Xuejing Zhang, Xueqin Yang, Zunyi Zhang, Ke‐Jie Yin, Huarong Huang · 2018 · Stem Cells and Development
78. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer
    Weikang Chen, Wenhao Zhang, Tao You Zhou, Jian Cai, Zhixian Yu, Zhigang Wu · 2021 · International Journal of General Medicine
79. The evolutionary conserved gene C16orf35 encodes a nucleo-cytoplasmic protein that interacts with p73
    Andrea Lunardi, Fulvio Chiacchiera, Elisa D’Este, Marcello Carotti, Marco Dal Ferro, Giulio Di Minin, Giannino Del Sal, Licio Collavin · 2009 · Biochemical and Biophysical Research Communications
80. Radiobiological Modifiers in Clinical Radiation Oncology: Current Reality and Future Potential
    Ron R. Allison · 2014 · Future Oncology
81. MicroRNA‑10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells
    Chenchu Lin, Wan‐Ting Liao, Tsung‐Ying Yang, Hsueh‐Ju Lu, Shih‐Lan Hsu, Chun‐Chi Wu · 2021 · Oncology Reports
82. SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
    María Gárate‐Rascón, Miriam Recalde, Carla Rojo, Maite G. Fernández‐Barrena, Matias Antonio Avila, María Arechederra, Carmen Berasain · 2022 · International Journal of Molecular Sciences
83. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase
    Jichun Yang, Jing Ma, Yu Xiong, Yanlin Wang, Kaiyue Jin, Wenjun Xia, Qing Chen, Jianbo Huang, Jin Zhang, Nan Jiang et al. · 2018 · Journal of Cellular Physiology
84. The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
    XH Wang, Daniel J O’Connor, Matthew Brimmell, Graham Packham · 2009 · British Journal of Cancer
85. Rethinking IRPs/IRE system in neurodegenerative disorders: looking beyond iron metabolism.
    Zheng-Yang Yao, Lin Fu, F. Jia, Ming-Xia Bi, Q. Jiao, Xi Chen, Xi-Xun Du, Hong Jiang · 2021 · Ageing Research Reviews
86. Atypical Atm–p53 genetic interaction in osteogenesis is mediated by Smad1 signaling
    Gang Ma, Lili Li, Yuanyu Hu, Jenny Fung Ling Chau, Bi Jin Au, Deyong Jia, Huijuan Liu, James Yeh, Lin He, Aijun Hao et al. · 2012 · Journal of Molecular Cell Biology
87. Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment
    Joana Almeida, Inês N. R. Mota, Jan Skoda, Emı́lia Sousa, Honorina M. Cidade, Lucı́lia Saraiva · 2022 · Cancers
88. Low dose arsenite confers resistance to UV induced apoptosis via p53-MDM2 pathway in ketatinocytes
    Yuzheng Zhou, Wenbin Zeng, Min Qi, Yanying Duan, Juan Su, S Zhao, W Zhong, Mingyang Gao, Feng Li, Yuhan He et al. · 2017 · Oncogenesis
89. Erythrosine B and quinoline yellow dyes regulate DNA repair gene expression in human HepG2 cells
    Farah Maria Drumond Chequer, Vinícius Paula Venâncio, Mara Ribeiro Almeida, Alexandre F. Aissa, Maria Lourdes Pires Bianchi, Lusânia Maria Greggi Antunes · 2017 · Toxicology and Industrial Health
90. Soy diet induces intestinal inflammation in adult Zebrafish: Role of OTX and P53 family
    Giovanni Micheloni, Marta Carnovali, Giorgia Millefanti, M Rizzetto, Vittoria Moretti, Giuseppe Montalbano, Francesco Acquati, Cristina Giaroni, Roberto Valli, Lucy Costantino et al. · 2021 · International Journal of Experimental Pathology
91. microRNA-Mediated Encoding and Decoding of Time-Dependent Signals in Tumorigenesis
    Simone Tealdi, Elsi Ferro, Carlo Cosimo Campa, Carla Bosia · 2022 · Biomolecules
92. Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype
    Nan Xu, Yue‐Yun Lai, Wen‐Min Chen, Hao Jiang, Yu Wang, Xu Wang, Xiaosu Zhao, Xiao‐Jun Huang, Qian Jiang, Ya‐Zhen Qin · 2022 · International Journal of Laboratory Hematology
93. Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
    Keting Li, Wenshu Hu, Yingjie Wang, Wenxing Chen, Hongmei Wen, Jian Liu, Wěi Li, Bo Wang · 2023 · Journal of Enzyme Inhibition and Medicinal Chemistry
94. p53 and p73 in suppression of Myc‐driven lymphomagenesis
    Heidi Griesmann, Katharina Schlereth, Michael Krause, Birgit Samans, Thorsten Stiewe · 2008 · International Journal of Cancer
95. A truncated p53 in human lung cancer cells as a critical determinant of proliferation and invasiveness
    Weiying Li, Baitang Lai, Xuehui Yang, Chunyan Zhang, Hui Wang · 2017 · Tumor Biology
96. Antioxidant Role of p53 and of Its Target TP53INP1
    Marion Seillier, Sylvain Peuget, Nelson Dusetti, Alice Carrier · 2012 · InTech eBooks
97. To Grow, Stop or Die? – Novel Tumor-Suppressive Mechanism Regulated by the Transcription Factor E2F
    Eiko Ozono, Shoji Yamaoka, Kiyoshi Ohtani · 2013 · InTech eBooks
98. Future Aspects of Tumor Suppressor Gene
    Yue Cheng · 2013 · InTech eBooks
99. Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer
    Àlvaro Quintanal-Villalonga, Mariló Mediano, Irene Ferrer, Ricardo Melendez, Andrés Carranza-Carranza, Rocío Aguilar Suárez, Amancio Carnero, Sonia Molina‐Pinelo, Luis G Paz-Ares · 2018 · Oncotarget
100. DLC2 inhibits development of glioma through regulating the expression ratio of TAp73α/TAp73β.
     Chao Cheng, Suyin Feng, Jiantong Jiao, Weiyi Huang, Jin Huang, Long Wang, Wei Jiang, J Chen, Min-chao Dai, Zheng Li et al. · 2018 · Europe PMC (PubMed Central)